NVCT

About Nuvectis Pharma, Inc. Common Stock (NVCT) Stock

Nuvectis Pharma, Inc. Common Stock (NVCT) closed the 2026-09-17 session at $20.54, down 6.10% versus the previous close (-1.34). The stock opened at $22.31 and traded between $20.54 and $22.31 during that session. Session trading volume was 83K shares. The volume-weighted average price (VWAP) is $21.33.

Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.

Nuvectis Pharma, Inc. Common Stock has a market capitalization of $713.9 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. NVCT is listed on the XNAS exchange. The company employs approximately 13 people. Nuvectis Pharma, Inc. Common Stock is headquartered in FORT LEE, NJ. The recorded listing date is 2022-02-04.

On this page you can find market NVCT stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.

Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.